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Rationale: Prevalence of malnutrition in patients with head and neck cancer (HNC) ranges from 15%>55%, as assessed by weight
loss. However, knowledge on the prevalence of malnutrition operationalized as multidimensional construct is lacking. Therefore, we
aimed to assess prevalence and characteristics of malnutrition risk by the Patient-Generated Subjective Global Assessment Short
Form (PG-SGA SF) in patients with newly diagnosed HNC.
Methods: Between August 2015 and January 2017, malnutrition risk was assessed by PG-SGA SF in 236 newly diagnosed HNC
outpatients. The PG-SGA SF includes four Boxes. Box 1 addresses history of weight loss; Box 2 changes in food intake; Box 3
nutrition impact symptoms (NIS); and Box 4 activities and function. ‘Medium risk’ was defined as 4-8 points, and ‘high risk’ as ≥9
points. PG-SGA ≥9 points indicates critical need for interventions.
Results: In total, 25.8% (61/236) of the patients were at medium risk for malnutrition, and 11.0 % (26/236) were at high risk.
Overall, median total point score was 2 (IQR: 0.0-5.75), and 7 (IQR: 5.0-9.0) in patients at medium/high malnutrition risk. In patients
at medium/high risk, highest score was on Box 3 (median 4; IQR: 2.0-5.0), mainly due to pain in the mouth or throat area (76.7%;
66/86), difficulties with swallowing (38.3%; 33/86), and lack of appetite (25.6%; 22/86). Median scores on Box 1, 2 and 4 were 1.
Mean weight loss in all patients was 1.3% in the last month and 2.9% in the last 6 months. In patients with malnutrition risk, mean
weight loss was 3.1% and 5.9%, respectively.
Conclusion: Our findings show that a substantial proportion of newly diagnosed HNC patients (36.8%) are at medium/high risk for
malnutrition, which is mainly related to specific NIS. These findings demonstrate that interdisciplinary symptom management and
nutritional intervention are indicated in this patient population.
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